These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 310015)

  • 21. Immunologic aspects of scleroderma.
    Kahaleh B
    Curr Opin Rheumatol; 1993 Nov; 5(6):760-5. PubMed ID: 8117539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases].
    Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP
    Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635
    [No Abstract]   [Full Text] [Related]  

  • 23. Abnormal lymphocyte function in scleroderma: a study on identical twins.
    Dustoor MM; McInerney MM; Mazanec DJ; Cathcart MK
    Clin Immunol Immunopathol; 1987 Jul; 44(1):20-30. PubMed ID: 2954728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte markers in patients with progressive systemic sclerosis.
    Czirják L; Dankó K; Sonkoly I; Bodolay E; Szegedi G
    Acta Med Hung; 1985; 42(3-4):109-14. PubMed ID: 2937012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of determining the lymphocyte subpopulations in the clinical evaluation of scleroderma in children].
    Levina SG; Geppa NA; Uvarova NN; Snesarevskaia IP
    Pediatriia; 1980 Apr; (4):50-2. PubMed ID: 6966790
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of T cells and cytokines in effecting fibrosis.
    Postlethwaite AE
    Int Rev Immunol; 1995; 12(2-4):247-58. PubMed ID: 7650423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma.
    Horwitz DA; Garrett MA
    Clin Exp Immunol; 1977 Jan; 27(1):92-9. PubMed ID: 300308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on pathophysiology of scleroderma with special reference to immunoinflammatory events.
    Chizzolini C
    Ann Med; 2007; 39(1):42-53. PubMed ID: 17364450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral blood lymphocyte distribution in scleroderma.
    Carapeto FJ; Winkelmann RK
    Dermatologica; 1975; 151(4):228-35. PubMed ID: 773715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunologic aspects of scleroderma.
    White B
    Curr Opin Rheumatol; 1995 Nov; 7(6):541-5. PubMed ID: 8579976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antinuclear, anti-DNA and anti-lymphocyte antibodies in systemic scleroderma. 62 cases].
    Dourdan P; Labro MT; Bourgeois P; Vinceneux P; Elias I; Kaplan G; Kahn MF
    Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):521-4. PubMed ID: 6604306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of autoimmune diseases: recent trends--with special reference to progress in immunological tests and therapeutic methods. Systemic autoimmune diseases. 2) Systemic scleroderma and polymyositis].
    Kinoshita M; Yokohari R
    Nihon Rinsho; 1988 Apr; 46(4):873-8. PubMed ID: 3261361
    [No Abstract]   [Full Text] [Related]  

  • 33. Scleroderma.
    Gilliam AC
    Curr Dir Autoimmun; 2008; 10():258-79. PubMed ID: 18460891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte responsiveness to urinary glycosaminoglycan in systemic scleroderma.
    Ishikawa H; Hattori A
    Dermatologica; 1979; 158(5):328-33. PubMed ID: 312217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytotoxic autoantibodies in progressive systemic sclerosis.
    Herrmann K; Schaller J; Haustein UF; Baldauf C; Kiessig S
    Arch Dermatol Res; 1988; 280(7):399-404. PubMed ID: 3264691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of the laboratory in rheumatology. Lymphocytes.
    Russell AS; Edelman J
    Clin Rheum Dis; 1983 Apr; 9(1):117-34. PubMed ID: 6603321
    [No Abstract]   [Full Text] [Related]  

  • 37. Stimulation of lymphocyte reactivity by a low molecular weight cutaneous antigen in patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Rheumatol; 1979; 6(1):30-7. PubMed ID: 374734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell receptors in scleroderma skin. The effect of photopheresis.
    Williams WV; Rook AH; Freundlich BF; Fang Q; Shaw E; Lessin S; Weiner DB
    Ann N Y Acad Sci; 1995 Jul; 756():424-7. PubMed ID: 7645864
    [No Abstract]   [Full Text] [Related]  

  • 39. [The presence of scleroderma and chronic lymphadenosis concurrently in a patient (author's transl)].
    Sandhofer M; Grond K; Kresbach H
    Wien Klin Wochenschr; 1975 Mar; 87(5):183-5. PubMed ID: 1078924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cellular immunity in lupus erythematosus and scleroderma].
    Gliński W; Langner A; Pawińska M
    Przegl Dermatol; 1976; (6 Suppl):329-34. PubMed ID: 1032181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.